• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT MEDICAL EPIC MAX VALVE (AORTIC); HEART-VALVE, NON-ALLOGRAFT TISSUE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT MEDICAL EPIC MAX VALVE (AORTIC); HEART-VALVE, NON-ALLOGRAFT TISSUE Back to Search Results
Catalog Number EMAX-21
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Hemorrhage/Bleeding (1888); Perforation (2001)
Event Date 02/07/2024
Event Type  Injury  
Manufacturer Narrative
Investigation is not yet complete.A follow-up report will be submitted with all additional relevant information.
 
Event Description
It was reported that on (b)(6) 2024, a 21mm epic max valve was chosen for implant.The patient was presented with small aortic root, requiring enlargement.The 21mm epic max valve was implanted.However, the patient started bleeding and atrioventricular dissection was noticed.The valve was explanted, and pericardial patch repair was performed.A replacement 19mm epic max valve was implanted.
 
Manufacturer Narrative
An event of explant due to bleeding from the aortic root was reported.Information from the field indicated that post-operatively the patient developed an ischemic lower extremity limb as a complication from a iabp that led to sepsis and end-organ injury and ultimately a fatality.The device was returned to abbott for investigation which revealed that the sewing cuff was intact and contained blood/bodily fluid.There were no perforations or tears observed and the cusps were mobile.The device history record was reviewed to ensure that each manufacturing and inspection operation was performed, and the product met all specifications.The cause of the reported event could not be conclusively determined.
 
Event Description
It was reported that on (b)(6) 2024, a 21mm epic max valve was chosen for implant in a 64-year-old female patient) with a history of aortic insufficiency, coronary artery disease and hypertension.The patient underwent an aortic valve replacement (avr) with a concomitant coronary artery bypass grafting (cabg) to the left anterior descending coronary artery (lad) using the left internal mammary artery (lima).The patient had a small aortic root with thin aortic tissue and an aortic enlargement was required.The aortic valve was sized for a 21 mm epic max valve using the replica sizer end of the epic max sizer set.The 21 mm sizer fit was good, and a decision was made to implant the 21mm epic max valve.The epic max 21mm was implanted without difficulty with the sutures secured using cor-knots.After coming off cardiopulmonary bypass it was noted that there was bleeding from the base of the aorta in the non-coronary sinus with visible pledgets consistent with an aortic-ventricular separation.The patient was placed back on cardiopulmonary bypass and the epic max 21mm valve was removed to expose the area of bleeding.The aortic bleeding site was repaired with autologous pericardial tissue and the valve was resized.Although an epic max 21mm valve was able to be fitted a decision was made to implant instead an epic max 19mm valve.The patient had difficulty coming off cardiopulmonary bypass due to the prolonged procedure and ultimately an intra-aortic balloon pump (iabp) was placed and the patient successfully came off cardiopulmonary bypass.Over the next few days the myocardial function recovered.However, the patient developed an ischemic lower limb as a complication from the iabp and needed to undergo a lower extremity amputation.However, a decision was made not to amputate the lower extremity and the patient developed sepsis with end-organ failure due to the ischemic lower extremity.The patient subsequently passed away.This issue reportedly caused a clinically significant delay due to having to remove, repair, and replace valve.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EPIC MAX VALVE (AORTIC)
Type of Device
HEART-VALVE, NON-ALLOGRAFT TISSUE
Manufacturer (Section D)
ABBOTT MEDICAL
5050 nathan lane n
plymouth MN 55442
Manufacturer Contact
karen krouse
5050 nathan lane n
plymouth, MN 55442
6517565400
MDR Report Key18801100
MDR Text Key336475563
Report Number2135147-2024-00919
Device Sequence Number1
Product Code LWR
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P040021
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial
Report Date 02/28/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue NumberEMAX-21
Device Lot NumberBR00038722
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 02/07/2024
Initial Date FDA Received02/28/2024
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured06/05/2023
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other; Required Intervention;
Patient Age64 YR
Patient SexFemale
-
-